PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Disease Inflammation 252,734 1 0.00 -0.87 0.25 0.58
Kappa-Type Opioid Receptor 4 Target Target Sphingosine 1-Phosphate Receptor 1 150 1 0.04 -0.86 0.25 0.77
Xaa-Pro Dipeptidase 4 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.87 0.25 0.64
Xaa-Pro Dipeptidase 4 Target Target EGF 27,487 1 0.00 -0.87 0.25 0.62
Abarelix (Plenaxis)- FDA 5 Drug Disease Breast Cancer 173,695 1 0.00 -0.89 0.20 0.58
Albenza (Albendazole)- FDA 5 Drug Drug Alinia (Nitazoxanide)- FDA 22 1 0.10 -0.87 0.20 0.84
Albenza (Albendazole)- FDA 5 Drug Drug Albendazole (Albenza)- FDA 5 5 1.00 -0.17 1.00 1.00
Almotriptan Malate (Axert)- FDA 5 Drug Disease Nausea 42,627 1 0.00 -0.89 0.20 0.61
Almotriptan Malate (Axert)- FDA 5 Drug Disease Headache 50,687 3 0.01 -0.63 0.60 0.63
Almotriptan Malate (Axert)- FDA 5 Drug Disease Migraine 24,200 5 0.01 -0.41 1.00 0.66